Literature DB >> 15539062

Trends in cigarette smoking among US adults with diabetes: findings from the Behavioral Risk Factor Surveillance System.

Earl S Ford1, Ali H Mokdad, Edward W Gregg.   

Abstract

BACKGROUND: Smoking substantially increases morbidity and mortality rates in people with diabetes. Previous studies have shown that the prevalence of smoking among people with diabetes is similar to that among people without diabetes. We sought to examine temporal trends in the prevalence of smoking among people with diabetes since 1990.
METHODS: We analyzed data from the Behavioral Risk Factor Surveillance System for 1990-2001.
RESULTS: The age-adjusted prevalence of smoking among adults with diabetes was 23.6% (men, 25.4%; women, 22.2%) in 1990 and 23.2% (men, 24.8%; women, 21.9%) in 2001. In comparison, the prevalence among participants without diabetes was 24.2% (men, 25.7%; women, 22.8%) in 1990 and 23.2% (men, 24.8%; women, 21.5%) in 2001. Thus, the prevalence of cigarette smoking was similar and remained stable from 1990 through 2001. Among participants with diabetes, significant decreases in the prevalence of smoking occurred among African Americans and those aged >/=65 years.
CONCLUSIONS: New efforts and commitments to promote smoking cessation among people with diabetes are needed.

Entities:  

Mesh:

Year:  2004        PMID: 15539062     DOI: 10.1016/j.ypmed.2004.04.039

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  21 in total

1.  Health-related behaviours in adults with diabetes: associations with health care utilization and costs.

Authors:  Ronald C Plotnikoff; Nandini D Karunamuni; Jeffrey A Johnson; Maria Kotovych; Lawrence W Svenson
Journal:  Can J Public Health       Date:  2008 May-Jun

2.  Effect of cigarette smoke extract on insulin transport in alveolar epithelial cell line A549.

Authors:  Mikihisa Takano; Taishi Horiuchi; Junya Nagai; Ryoko Yumoto
Journal:  Lung       Date:  2012-09-08       Impact factor: 2.584

3.  Prevalence of tobacco use and association between cardiometabolic risk factors and cigarette smoking in youth with type 1 or type 2 diabetes mellitus.

Authors:  Kristi Reynolds; Angela D Liese; Andrea M Anderson; Dana Dabelea; Debra Standiford; Stephen R Daniels; Beth Waitzfelder; Doug Case; Beth Loots; Giuseppina Imperatore; Jean M Lawrence
Journal:  J Pediatr       Date:  2010-12-03       Impact factor: 4.406

4.  Health professional advice for smoking and weight in adults with and without diabetes: findings from BRFSS.

Authors:  Gillian L Schauer; Abigail C Halperin; Lloyd A Mancl; Mark P Doescher
Journal:  J Behav Med       Date:  2011-11-16

Review 5.  Inhaled insulin: overview of a novel route of insulin administration.

Authors:  Lucy D Mastrandrea
Journal:  Vasc Health Risk Manag       Date:  2010-03-03

Review 6.  Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models.

Authors:  Lauren C Smith; Olivier George
Journal:  Neuropharmacology       Date:  2020-08-03       Impact factor: 5.250

Review 7.  Effectiveness of Non-Primary Care-Based Smoking Cessation Interventions for Adults with Diabetes: A Systematic Literature Review.

Authors:  Shilpa J Register; Kathy F Harrington; April A Agne; Andrea L Cherrington
Journal:  Curr Diab Rep       Date:  2016-09       Impact factor: 4.810

Review 8.  Cigarette Smoking, Diabetes, and Diabetes Complications: Call for Urgent Action.

Authors:  Ping Zhu; Xiong-Fei Pan; Liting Sheng; Henggui Chen; An Pan
Journal:  Curr Diab Rep       Date:  2017-09       Impact factor: 4.810

9.  Tobacco use patterns and clinical outcomes in the T1D exchange.

Authors:  Carla J Rash; Sheila M Alessi; Nicole Foster; William Tamborlane; Michelle A Van Name; Julie A Wagner
Journal:  J Diabetes Complications       Date:  2022-01-12       Impact factor: 2.852

10.  Use and effectiveness of quitlines for smokers with diabetes: cessation and weight outcomes, Washington State Tobacco Quit Line, 2008.

Authors:  Gillian L Schauer; Terry Bush; Barbara Cerutti; Lisa Mahoney; Juliet R Thompson; Susan M Zbikowski
Journal:  Prev Chronic Dis       Date:  2013-07-03       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.